Aroor, Annayya R <br/><br/>
The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.  [electronic resource] 

 -  Cardiovascular diabetology  04 2018 
 - 59 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1475-2840 
<br/><br/><label>Standard No.: </label>10.1186/s12933-018-0704-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cardiovascular Diseases--drug therapy<br/>Comorbidity<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Diabetic Angiopathies--drug therapy<br/>Dipeptidyl Peptidase 4--metabolism<br/>Dipeptidyl-Peptidase IV Inhibitors--adverse effects<br/>Humans<br/>Linagliptin--adverse effects<br/>Risk Factors<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Treatment Outcome